Published guidance, NICE advice and quality standards | Guidance

Showing 641 to 650 of 911

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Pemetrexed for the maintenance treatment of non-small-cell lung cancer	TA190	23 June 2010	10 August 2017
Cabozantinib for previously treated advanced renal cell carcinoma	TA463	9 August 2017	9 August 2017
Baricitinib for moderate to severe rheumatoid arthritis	TA466	9 August 2017	9 August 2017
Adalimumab and dexamethasone for treating non-infectious uveitis	TA460	26 July 2017	26 July 2017
Roflumilast for treating chronic obstructive pulmonary disease	TA461	26 July 2017	26 July 2017
Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma	TA462	26 July 2017	26 July 2017
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people	TA455	12 July 2017	12 July 2017
Ustekinumab for moderately to severely active Crohn's disease after previous treatment	TA456	12 July 2017	12 July 2017
Ibrutinib for untreated chronic lymphocytic leukaemia without a 17p deletion or TP53 mutation (terminated appraisal)	TA452	5 July 2017	5 July 2017
Bortezomib for treating multiple myeloma after second or subsequent relapse (terminated appraisal)	TA453	5 July 2017	5 July 2017